CHK. Well that was a pretty weak anncmnt for an overbought stock. Was always more likely to get sold off.
And the guts of the anncmnt is that it will be quite a while b4 any concrete data comes along. Nearology is a bit of a beat up in this game.
Admittedly they are really able to push these stocks if they want and some might take the odds. Just not my thing as I won't buy a chart like that.
